Jude Medical Unveils Latest Product at American Academy of Pain Medicine Annual Meeting Army Parachutist Becomes First Person Implanted with the Eon Mini neurostimulator, the World’s Smallest Neurostimulator to Manage Chronic Pain. News Release: First Person Implanted with the Eon Mini Neurostimulator, the World’s Smallest Neurostimulator for Chronic Painįormer U.S. Jude Medical Receives FDA and CE Mark Approvals for the World’s Smallest, Longest-Lasting Rechargeable Neurostimulator to Manage Chronic Pain. Jude Medical Receives FDA and CE Mark Approvals for Eon Mini Neurostimulator The Eon Mini spinal cord stimulator - world’s smallest, longest-lasting rechargeable neurostimulator to manage chronic pain - combines greater patient comfort with 10-year battery longevity Jude Medical Announces Approval of the First Rechargeable Neurostimulator to Manage Chronic Pain in Japan Innovative Penta surgical lead receives European CE Mark and Australian TGA regulatory approvals Jude Medical Announces New Approvals of Five-Column Neurostimulation Lead to Manage Chronic Pain at 14th Annual North American Neuromodulation Society Meeting Results presented today at the 14th annual North American Neuromodulation Society meeting show that 70 percent of patients report overall pain relief Jude Medical Neurostimulation Study Demonstrates Sustained Improvement in Chronic Low Back Pain Symptoms and Quality of Life Description (Click below to link to more info) The Spinal Cord Stimulation media kit includes news releases, backgrounders, illustrations, photographs and animations.Ĭredit any images and video as follows: Images or video provided courtesy of St. Spinal cord stimulation is used for the management of chronic pain of the trunk and limbs. Female candidates of child bearing potential who are pregnant (confirmed by positive urine/blood pregnancy test), not using adequate contraception as determined by the investigator, or nursing (lactating) a child.Spinal Cord Stimulation for Chronic Pain Media Kit.Patient is not willing to maintain current medication regimen.Patient with demand-type cardiac pacemakers, an infusion pump or any other implantable neurostimulator device except for the spinal cord stimulator under study.Patient currently participating in another clinical study.Patient has history of substance abuse or substance dependency in the past 6 months prior to baseline data collection.Patient has a history of life-threatening severe illness or is suffering from severe chronic disease other than the indication for the study.Patient has current evidence of any psychiatric disorder, as documented by the DSM-IV-TR criteria with psychotic characteristics.Patient is willing to cooperate with the study requirements including compliance with the treatment regimen and completion of all office visits.Ī patient will be excluded from participation in this study if they meet any one of the following criteria:.Patient agrees not to add or increase medication throughout the randomization trial period of the study.Patient medication has remained stable for at least 4 weeks prior to baseline data collection.Patient has a simulator implanted at the dorsal column spinal cord powered by an EON/EON Mini® internal pulse generator.Patient has Failed Back Surgery Syndrome.Patient is between the age of 18 and 75.Patients able to provide informed consent to participate in the study.Patients enrolled in this study must meet the following inclusion criteria:.After authorization by the psychologist and psychiatrist an implant was offered. Why Should I Register and Submit Results?Īll patients were selected after multidisciplinary discussion with a specialized pain physician, a psychological and psychiatric evaluation was performed to rule out psychogenic pain as well as other psychiatric morbidity contraindicating an implant.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |